BSE Live
Feb 02, 16:01Prev. Close
1610.20
Open Price
1627.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Feb 02, 15:59Prev. Close
1610.10
Open Price
1634.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1627.90 (437)
| Key Financial Ratios of Sun Pharmaceutical Industries (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 65.23 | 88.33 | 71.79 | 40.55 | 30.86 | |
| Diluted EPS (Rs.) | 65.23 | 88.33 | 71.79 | 40.55 | 30.86 | |
| Cash EPS (Rs.) | 72.44 | 97.19 | 79.56 | 47.64 | 34.13 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 387.32 | 349.65 | 250.10 | 145.56 | 87.32 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 387.32 | 349.65 | 250.10 | 145.56 | 87.32 | |
| Revenue from Operations/Share (Rs.) | 188.45 | 206.62 | 162.24 | 110.24 | 88.19 | |
| PBDIT/Share (Rs.) | 75.93 | 100.34 | 82.26 | 47.96 | 36.26 | |
| PBIT/Share (Rs.) | 68.53 | 94.39 | 77.59 | 43.75 | 32.97 | |
| PBT/Share (Rs.) | 68.23 | 94.11 | 77.16 | 43.10 | 32.14 | |
| Net Profit/Share (Rs.) | 65.03 | 91.24 | 74.88 | 43.44 | 30.85 | |
| NP After MI And SOA / Share (Rs.) | 65.23 | 88.33 | 71.79 | 40.55 | 30.86 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 40.29 | 48.56 | 50.70 | 43.50 | 41.11 | |
| PBIT Margin (%) | 36.36 | 45.68 | 47.82 | 39.68 | 37.39 | |
| PBT Margin (%) | 36.20 | 45.54 | 47.56 | 39.09 | 36.44 | |
| Net Profit Margin (%) | 34.50 | 44.15 | 46.15 | 39.40 | 34.97 | |
| NP After MI And SOA Margin (%) | 34.61 | 42.74 | 44.24 | 36.78 | 34.99 | |
| Return on Networth/Equity (%) | 17.25 | 25.96 | 29.78 | 28.29 | 36.08 | |
| Return on Capital Employed (%) | 17.33 | 26.47 | 29.52 | 21.04 | 17.67 | |
| Return on Assets (%) | 14.89 | 22.13 | 24.20 | 17.85 | 14.46 | |
| Total Debt/Equity (X) | 0.02 | 0.03 | 0.03 | 0.40 | 1.18 | |
| Asset Turnover Ratio (%) | 0.45 | 0.59 | 0.64 | 0.51 | 0.45 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 4.20 | 4.86 | 5.76 | 8.06 | 5.33 | |
| Quick Ratio (X) | 2.99 | 3.75 | 4.66 | 6.27 | 4.30 | |
| Inventory Turnover Ratio (X) | 1.11 | 1.26 | 1.04 | 1.31 | 1.56 | |
| Dividend Payout Ratio (NP) (%) | 21.07 | 15.56 | 14.62 | 16.57 | 17.84 | |
| Dividend Payout Ratio (CP) (%) | 18.93 | 14.58 | 13.73 | 15.02 | 16.12 | |
| Earnings Retention Ratio (%) | 78.93 | 84.44 | 85.38 | 83.43 | 82.16 | |
| Cash Earnings Retention Ratio (%) | 81.07 | 85.42 | 86.27 | 84.98 | 83.88 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | 255.73 | 355.27 | 194.50 | 73.15 | 43.28 | |
| Interest Coverage Ratios (Post Tax) (%) | 255.73 | 355.27 | 194.50 | 73.15 | 43.28 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 36,823.26 | 21,745.89 | 24,498.76 | 20,163.71 | 16,469.32 | |
| EV/Net Operating Revenue (X) | 9.43 | 5.08 | 7.29 | 9.46 | 10.05 | |
| EV/EBITDA (X) | 23.41 | 10.46 | 14.38 | 21.74 | 24.45 | |
| MarketCap/Net Operating Revenue (X) | 9.50 | 5.38 | 7.59 | 9.56 | 9.82 | |
| Retention Ratios (%) | 78.92 | 84.43 | 85.37 | 83.42 | 82.15 | |
| Price/BV (X) | 4.73 | 3.27 | 5.11 | 7.36 | 10.13 | |
| Price/Net Operating Revenue | 9.50 | 5.38 | 7.59 | 9.56 | 9.82 | |
| Earnings Yield | 0.04 | 0.08 | 0.06 | 0.04 | 0.04 |
01.02.2026
07.01.2026
20.11.2025
12.11.2025
11.11.2025
Sun Pharma Standalone September 2025 Net Sales at Rs 4,548.11 crore, down 11.3% Y-o-Y
01.08.2025
Sun Pharma Consolidated June 2025 Net Sales at Rs 13,851.40 crore, up 9.47% Y-o-Y
31.07.2025
Sun Pharma Standalone June 2025 Net Sales at Rs 5,601.96 crore, up 24.54% Y-o-Y
22.05.2025
Sun Pharma Q4 net profit declines 19% to Rs 2,154 crore, firm declares Rs 5.50 dividend